Presenter: Lindsey Murphy, MD, MSCS This presentation reviews the evolving role of CAR T-cell therapy in the treatment of relapsed and refractory pediatric leukemia. Participants will examine CAR T-cell fundamentals, indications for therapy, and current clinical applications. The session focuses on the recognition, grading, and management...
Presenter: Jody Pathare, MSN, FNP, CPHON This presentation examines the growing role of targeted therapies in pediatric oncology and the unique supportive care challenges associated with precision medicine. Participants will review molecular pathways commonly targeted in pediatric cancers, recognize treatment-related toxicities, and discuss strategies for monitoring...
Presenter: Jennifer Yu, MD This presentation reviews current and emerging treatment approaches for thalassemia, including novel medications and recently approved gene therapies. Participants will examine disease pathophysiology, patient eligibility considerations, and the benefits and limitations of available treatment options. The session also addresses the long-term medical...
Presenter: Lauren Guidry This presentation reviews advances in pediatric leukemia treatment, including evolving risk stratification methods, molecular profiling, immunotherapy, and emerging treatment approaches. Participants will explore how these innovations are improving outcomes while reducing treatment-related toxicity. The session also addresses nursing considerations related to treatment monitoring,...
